The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action

被引:92
|
作者
Honeywell-Nguyen, PL [1 ]
Bouwstra, JA [1 ]
机构
[1] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Dept Pharmaceut Technol, Gorlaeus Labs, NL-2300 RA Leiden, Netherlands
关键词
transdermal delivery; elastic vesicles; pergolide;
D O I
10.1016/S0168-3659(02)00415-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This paper reports the in vitro transport of pergolide from L-595-PEG-8-L elastic vesicle formulations. Several aspects of vesicular delivery were studied in order to elucidate the possible mechanisms of action and to establish the optimal conditions and drug candidates for usage with L-595-PEG-8-L elastic vesicles. All studies were performed using human skin and flow-through Franz diffusion cells. Pergolide was chosen as model drug. The findings show that there was a strong correlation between the drug incorporation to saturated levels and the drug transport, both of which were influenced by the pH of the drug-vesicular system. The optimal pH was found to be 5.0, giving the highest drug incorporation as well as the highest drug transport. Non-occlusive co-treatment with elastic vesicles improved the skin delivery of pergolide compared to the non-occlusive,buffer control by more than 2-fold. However, non-occlusive pre-treatment of skin with empty vesicles did not enhance drug transport. Occlusion improved drug transport from both elastic vesicle as well as buffer solutions due to the fact that water is an excellent penetration enhancer for pergolide. However, in contrast to non-occlusive application, the action of the elastic vesicles themselves was diminished, as occlusive treatments with elastic vesicles showed a lower flux compared to occlusive treatment with the buffer control. Hence, the highest pergolide skin permeation in this study was obtained from an occluded saturated buffer solution, giving a steady-state flux of 137.9 ng/h cm(-2). The volume of application did not have any effect on the drug transport. In conclusion, these results showed no evidence that a penetration enhancing effect is the main mechanism of action. The pH of the drug-vesicular system is an important factor to consider when optimising elastic vesicle delivery systems. Occlusion reduces the actions of elastic vesicles, but could increase the pergolide transport since water is a good penetration enhancer for this particular drug. Based on the results obtained, a mechanism of action for the elastic vesicles was proposed. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:145 / 156
页数:12
相关论文
共 12 条
  • [1] Transdermal Delivery of Pergolide from Surfactant-Based Elastic and Rigid Vesicles: Characterization and in Vitro Transport Studies
    P. Loan Honeywell-Nguyen
    Peter M. Frederik
    Paul H. H. Bomans
    Hans E. Junginger
    Joke A. Bouwstra
    [J]. Pharmaceutical Research, 2002, 19 : 991 - 997
  • [2] Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles:: Characterization and in vitro transport studies
    Honeywell-Nguyen, PL
    Frederik, PM
    Bomans, PHH
    Junginger, HE
    Bouwstra, JA
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 991 - 997
  • [3] The effect of surfactant-based elastic and rigid vesicles on the penetration of lidocaine across human skin
    Honeywell-Nguyen, PL
    Van den Bussche, MH
    Junginger, HE
    Bouwstra, JA
    [J]. STP PHARMA SCIENCES, 2002, 12 (04): : 257 - 262
  • [4] Transdermal delivery of flurbiprofen from surfactant-based vesicles: Particle characterization and the effect of water on in vitro transport
    Uchino, Tomonobu
    Matsumoto, Yuiko
    Murata, Akiko
    Oka, Toshihiko
    Miyazaki, Yasunori
    Kagawa, Yoshiyuki
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 464 (1-2) : 75 - 84
  • [5] Modulation mechanism of the stratum corneum structure during permeation of surfactant-based rigid and elastic vesicles
    Uchino, Tomonobu
    Hatta, Ichiro
    Miyazaki, Yasunori
    Onai, Tomoya
    Yamazaki, Takuto
    Sugiura, Fuyoko
    Kagawa, Yoshiyuki
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 521 (1-2) : 222 - 231
  • [6] Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations
    Honeywell-Nguyen, PL
    Arenja, S
    Bouwstra, JA
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (10) : 1619 - 1625
  • [7] Skin Penetration and Mechanisms of Action in the Delivery of the D2-Agonist Rotigotine from Surfactant-Based Elastic Vesicle Formulations
    P. Loan Honeywell-Nguyen
    Sonia Arenja
    Joke A. Bouwstra
    [J]. Pharmaceutical Research, 2003, 20 : 1619 - 1625
  • [8] Diffusion of estradiol from non-ionic surfactant vesicles through human stratum corneum in vitro
    VanHal, D
    VanRensen, A
    deVringer, T
    Junginger, H
    Bouwstra, J
    [J]. STP PHARMA SCIENCES, 1996, 6 (01): : 72 - 78
  • [9] Effect of Elastic Liquid-State Vesicle on Apomorphine Iontophoresis Transport Through Human Skin In Vitro
    Gai Ling Li
    Meindert Danhof
    Joke A. Bouwstra
    [J]. Pharmaceutical Research, 2001, 18 : 1627 - 1630
  • [10] Effect of elastic liquid-state vesicle on apomorphine iontophoresis transport through human skin in vitro
    Li, GL
    Danhof, M
    Bouwstra, JA
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (11) : 1627 - 1630